Page last updated: 2024-10-30

letrozole and Dermatitis

letrozole has been researched along with Dermatitis in 1 studies

Dermatitis: Any inflammation of the skin.

Research Excerpts

ExcerptRelevanceReference
"Letrozole radiosensitises breast cancer cells in vitro."9.14Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. ( Azria, D; Belkacemi, Y; Coelho, M; Crompton, NE; Fenoglietto, P; Gourgou, S; Gutowski, M; Lemanski, C; Moscardo, CL; Ozsahin, M; Romieu, G; Rosenstein, B; Zaman, K, 2010)
"Letrozole radiosensitises breast cancer cells in vitro."5.14Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. ( Azria, D; Belkacemi, Y; Coelho, M; Crompton, NE; Fenoglietto, P; Gourgou, S; Gutowski, M; Lemanski, C; Moscardo, CL; Ozsahin, M; Romieu, G; Rosenstein, B; Zaman, K, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azria, D1
Belkacemi, Y1
Romieu, G1
Gourgou, S1
Gutowski, M1
Zaman, K1
Moscardo, CL1
Lemanski, C1
Coelho, M1
Rosenstein, B1
Fenoglietto, P1
Crompton, NE1
Ozsahin, M1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase II Randomized Study to Compare Skin Late Toxicities of Concomitant Letrozole-Radiotherapy and Radiotherapy Followed by Letrozole as Adjuvant Therapy for Postmenopausal Women With Receptor (ER and/or PgR) Positive Tumors[NCT00208273]Phase 2150 participants (Actual)Interventional2005-01-31Completed
Feasibility Clinical Trial of Intraoperative Radiotherapy (IORT) and Second Breast-conserving-surgery After Local Recurrence of Breast Carcinoma[NCT02386371]66 participants (Actual)Interventional2014-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for letrozole and Dermatitis

ArticleYear
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
    The Lancet. Oncology, 2010, Volume: 11, Issue:3

    Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Dermatit

2010
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
    The Lancet. Oncology, 2010, Volume: 11, Issue:3

    Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Dermatit

2010
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
    The Lancet. Oncology, 2010, Volume: 11, Issue:3

    Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Dermatit

2010
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
    The Lancet. Oncology, 2010, Volume: 11, Issue:3

    Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Dermatit

2010